1941 - 1950 of 6256 Results
Title
Year
- Olfactory Dysfunction and Long-Term Trajectories of Sleep Disorders among early Parkinson’s Disease: Findings from a Longitudinal Cohort2024OPENTitle: Olfactory Dysfunction and Long-Term Trajectories of Sleep Disorders among early Parkinson’s Disease: Findings from a Longitudinal CohortJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol:Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000539330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11797938Citation Count: 1
- The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines2022OPENTitle: The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell linesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac233Best OA location URL: https://academic.oup.com/hmg/article-pdf/32/5/773/49283269/ddac233.pdfCitation Count: 11
-
OPENTitle: Large-scale biophysically detailed model of somatosensory thalamocortical circuits in NetPyNEJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fninf.2022.884245Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2022.884245/pdfCitation Count: 20
- Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia2017OPENTitle: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-017-0276-4Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-017-0276-4Citation Count: 119
-
OPENTitle: Large-scale assessment of polyglutamine repeat expansions in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 15Start Page: 1283End Page: 1292Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000002016Best OA location URL: https://n.neurology.org/content/neurology/85/15/1283.full.pdfCitation Count: 27
-
OPENTitle: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 19Start Page: 1944End Page: 1950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9aBest OA location URL: https://n.neurology.org/content/neurology/79/19/1944.full.pdfCitation Count: 148
- Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's Disease2024OPENTitle: Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 16Issue #: 1Start Page: 0End Page: 0Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14336/ad.2024.0323Best OA location URL: https://doi.org/10.14336/ad.2024.0323Citation Count: 0
- A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease2024OPENTitle: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549Best OA location URL: https://doi.org/10.3389/fnmol.2024.1431549Citation Count: 0
- Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease2023OPENTitle: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105822End Page: 105822Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105822Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10853986Citation Count: 3
- Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine2024OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107158Citation Count: 2